Cargando…
4-[(4′-Chloromethyl-[1,1′-biphenyl]-4-yl)methyl]bis(dimethylglyoximato-κ(2) N,N′)(pyridine-κN)cobalt(III)
The title compound, [Co(C(14)H(14)Cl)(C(4)H(6)N(2)O(2))(2)(C(5)H(5)N)], is a model compound for the more complex cobalamines like vitamins B(12). The Co(III) atom is coordinated by a (4′-chloromethyl-[1,1′-biphenyl]-4-yl)methyl group, an N-bonded pyridine and two N,N′-bidentate dimethylglyoximate...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274891/ https://www.ncbi.nlm.nih.gov/pubmed/22346838 http://dx.doi.org/10.1107/S1600536812001092 |
_version_ | 1782223129015222272 |
---|---|
author | Kumar, Sarvendra Thapa, Suresh |
author_facet | Kumar, Sarvendra Thapa, Suresh |
author_sort | Kumar, Sarvendra |
collection | PubMed |
description | The title compound, [Co(C(14)H(14)Cl)(C(4)H(6)N(2)O(2))(2)(C(5)H(5)N)], is a model compound for the more complex cobalamines like vitamins B(12). The Co(III) atom is coordinated by a (4′-chloromethyl-[1,1′-biphenyl]-4-yl)methyl group, an N-bonded pyridine and two N,N′-bidentate dimethylglyoximate ligands in a distorted octahedral geometry. The glyoximate ligands exhibit intramolecular O—H⋯O hydrogen bonds, which is very common in cobaloxime derivatives. |
format | Online Article Text |
id | pubmed-3274891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-32748912012-02-15 4-[(4′-Chloromethyl-[1,1′-biphenyl]-4-yl)methyl]bis(dimethylglyoximato-κ(2) N,N′)(pyridine-κN)cobalt(III) Kumar, Sarvendra Thapa, Suresh Acta Crystallogr Sect E Struct Rep Online Metal-Organic Papers The title compound, [Co(C(14)H(14)Cl)(C(4)H(6)N(2)O(2))(2)(C(5)H(5)N)], is a model compound for the more complex cobalamines like vitamins B(12). The Co(III) atom is coordinated by a (4′-chloromethyl-[1,1′-biphenyl]-4-yl)methyl group, an N-bonded pyridine and two N,N′-bidentate dimethylglyoximate ligands in a distorted octahedral geometry. The glyoximate ligands exhibit intramolecular O—H⋯O hydrogen bonds, which is very common in cobaloxime derivatives. International Union of Crystallography 2012-01-14 /pmc/articles/PMC3274891/ /pubmed/22346838 http://dx.doi.org/10.1107/S1600536812001092 Text en © Kumar and Thapa 2012 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited. |
spellingShingle | Metal-Organic Papers Kumar, Sarvendra Thapa, Suresh 4-[(4′-Chloromethyl-[1,1′-biphenyl]-4-yl)methyl]bis(dimethylglyoximato-κ(2) N,N′)(pyridine-κN)cobalt(III) |
title | 4-[(4′-Chloromethyl-[1,1′-biphenyl]-4-yl)methyl]bis(dimethylglyoximato-κ(2)
N,N′)(pyridine-κN)cobalt(III)
|
title_full | 4-[(4′-Chloromethyl-[1,1′-biphenyl]-4-yl)methyl]bis(dimethylglyoximato-κ(2)
N,N′)(pyridine-κN)cobalt(III)
|
title_fullStr | 4-[(4′-Chloromethyl-[1,1′-biphenyl]-4-yl)methyl]bis(dimethylglyoximato-κ(2)
N,N′)(pyridine-κN)cobalt(III)
|
title_full_unstemmed | 4-[(4′-Chloromethyl-[1,1′-biphenyl]-4-yl)methyl]bis(dimethylglyoximato-κ(2)
N,N′)(pyridine-κN)cobalt(III)
|
title_short | 4-[(4′-Chloromethyl-[1,1′-biphenyl]-4-yl)methyl]bis(dimethylglyoximato-κ(2)
N,N′)(pyridine-κN)cobalt(III)
|
title_sort | 4-[(4′-chloromethyl-[1,1′-biphenyl]-4-yl)methyl]bis(dimethylglyoximato-κ(2)
n,n′)(pyridine-κn)cobalt(iii) |
topic | Metal-Organic Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274891/ https://www.ncbi.nlm.nih.gov/pubmed/22346838 http://dx.doi.org/10.1107/S1600536812001092 |
work_keys_str_mv | AT kumarsarvendra 44chloromethyl11biphenyl4ylmethylbisdimethylglyoximatok2nnpyridinekncobaltiii AT thapasuresh 44chloromethyl11biphenyl4ylmethylbisdimethylglyoximatok2nnpyridinekncobaltiii |